Clinical Trial Update: Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing chemotherapy plus quizartinib versus chemotherapy plus placebo in adults with FLT3-wild-type acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Quizartinib (AC220) (quizartinib)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED